Search | LIFE-ND Graduate Community

added blog Health

2026-07-16 06:39:49 -

Regorafenib Tablets Market Size, Share & Growth Analysis Report, 2025–2035

The Regorafenib Tablets Market continues to expand as targeted cancer therapies become increasingly important in modern oncology. Regorafenib is an oral multi-kinase inhibitor prescribed for the treatment of specific advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). As cancer incidence rises globally and...

0 Comments 0 Shares 72 Views 0 Reviews